Pre-Open Stock Movers 05/19: (LPTH) (RETA) (TTWO) Higher; (MARA) (RIOT) (COIN) Lower (more...)

Target (TGT) PT Raised to $245 at BMO Capital

BMO Capital analyst Kelly Bania raised the price target on Target (NYSE: TGT) to $245.00 while maintaining an Outperform rating.

The analyst commented, "TGT's F1Q21 earnings continued to benefit from a clearly favorable consumer backdrop, but also impressive market share... More

Lithia Motors (LAD) Prices 3.1M Share Common Offering at $322/Sh

Lithia Motors & Driveway (NYSE: LAD) today announced the pricing of its public offering (the "Offering") of 3,105,590 shares of its Class A common stock (the "common stock") at a price to the public of $322.00 per share. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 465,838 shares of common stock at the same public offering price, less underwriting discounts and commissions. The offering is expected to close on May 24, 2021, subject to the satisfaction of customary closing conditions.

In addition, today Lithia concurrently announced the pricing of its private... More

Target (TGT) PT Raised to $265 at Telsey Highlighting 4 Key Initiatives

Telsey analyst Joseph Feldman raised the price target on Target (NYSE: TGT) to $265.00 (from $235.00) after the company reported 1Q21 adjusted EPS of $3.69, significantly above the FactSet (FS) consensus of $2.21, with a total comp of 22.9% (traffic up 17.1%; ticket up 5.0%) vs. our forecast 12.0% and FS at 11.9%... More

Iovanace Biotherapeutics (IOVA) Has Strong Cash Cushion Even as CEO Exit Adds to Uncertainties - Mizuho

Mizuho Securities analyst Mara Goldstein weighed in on Iovanace Biotherapeutics (NASDAQ: IOVA) after the company announced that Maria Fardis, Ph.D. will resign as President and CEO of the company following today's regulatory setback.

"The commercial potential for lifileucel remains but the question... More